July 24, 2026 - 01:49

Hillsborough County investigators say they have finally closed the books on three long-unsolved homicides, thanks to breakthroughs in DNA technology. The Hillsborough County Sheriff's Office announced the resolutions this week, bringing a measure of closure to families who waited years for answers.
The cases, which had gone cold for decades, were reopened as part of a renewed effort to apply modern forensic methods to old evidence. In each instance, detectives were able to extract usable genetic material from items that had been stored since the original investigations. That material was then run through updated databases, leading to matches that had not been possible when the crimes occurred.
Sheriff Chad Chronister credited the department's cold case unit and partnerships with private DNA labs for the progress. He noted that the technology has evolved rapidly, allowing analysts to work with smaller and more degraded samples than ever before. The three cases span different years and locations across the Tampa Bay area, but all shared the common thread of stalled leads and dwindling hope.
While officials did not release the names of the victims or suspects, they confirmed that arrests have been made or charges filed in each case. The announcements serve as a reminder that even the oldest cases can yield new results when science catches up with the evidence. For the families involved, the news ends a painful chapter of uncertainty.
September 30, 2026 - 01:50
Space Force Turns to Laser Systems to Shield Launch Sites from Drone ThreatsThe U.S. Space Force is moving forward with plans to deploy laser technology as part of a broader effort to defend its launch facilities from unauthorized drones. The initiative focuses on...
September 29, 2026 - 04:58
DIU Seeks Investors in Counter-Unmanned Systems TechnologyThe Defense Innovation Unit is looking for private investors to back companies working on counter unmanned systems technology. The effort targets firms building tools to detect, track, and disable...
September 28, 2026 - 02:02
Novo Nordisk (CPSE:NOVO B) Secures Long-Acting Injectable Technology In €1.165 Billion Nanexa Licensing AgreementNovo Nordisk has entered a global licensing agreement with Swedish drug delivery company Nanexa, valued at up to 1.165 billion euros. The deal centers on Nanexa`s PharmaShell technology, a platform...
September 27, 2026 - 08:32
New Biochip Enables Real-Time Tracking of Parkinson's Treatment ResponseResearchers have created a biochip technology that allows for real-time monitoring of how Parkinson`s disease patients respond to treatment. The development comes from a team working on advanced...